Robeco Institutional Asset Management Boosts VEEV Holdings 1

Veeva Systems, Inc. is a global cloud solutions provider for the life sciences industry that offers pharmaceutical and other life sciences companies modern cloud-based architectures and mobile applications while ensuring regulatory compliance. Several hedge funds and insiders have recently modified their holdings of VEEV. A director sold 2,658 shares of the stock in a transaction dated March 3rd, while another director sold 160 shares of the firm’s stock in a transaction dated March 10th. Moreover, in the last 90 days, insiders sold 97,224 shares of company stock worth $16,003,460. To get the latest 13F filings and insider trades for Veeva Systems Inc., visit HoldingsChannel.com. Additionally, you can enter your email address to receive a concise daily summary of the latest news and analysts’ ratings for Veeva Systems and related companies with MarketBeat.com’s FREE daily email newsletter.

Robeco Institutional Asset Management B.V. Increases Stake in Veeva Systems Inc.

Veeva Systems logo

Robeco Institutional Asset Management B.V. has increased its stake in Veeva Systems Inc. by 15.9% during the third quarter, according to the company’s recent 13F filing. The Dutch asset manager now owns 9,009 shares of the technology company’s stock.

Several other large investors have also modified their holdings of VEEV, including Price T Rowe Associates Inc. MD, Vanguard Group Inc., Artisan Partners Limited Partnership, AllianceBernstein L.P., and State Street Corp. Collectively, institutional investors now own 78.76% of the stock.

Veeva Systems has been the subject of numerous research reports, with a total of 12 analysts rating the stock as a hold, and 13 rating it as a buy. MarketBeat.com data reveals that the company presently has a consensus rating of “Moderate Buy” and an average target price of $204.39.

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Despite these ratings, Veeva Systems’ stock price has been trading down by 1.8%. KeyCorp, Oppenheimer, and Morgan Stanley have all reduced their price objectives on the stock, while Piper Sandler has upped its price objective from $204.00 to $212.00 in a report on Thursday, March 2nd.

VEEV Stock Information and Insider Trading

Veeva Systems Inc. (VEEV) opened at $172.63 on Friday and has a 50-day moving average price of $169.92 and a 200-day moving average price of $170.24. The technology company’s stock has a market capitalization of $26.88 billion, a PE ratio of 57.35, a price-to-earnings-growth ratio of 3.92, and a beta of 0.90. VEEV’s 52-week low is $151.02, and its 52-week high is $232.26.

Insider trading activity at VEEV has been reported recently, with Director Paul J. Sekhri selling 2,658 shares of the stock on March 3rd at an average price of $181.93, for a total transaction of $483,569.94. Following the completion of the transaction, the director now owns 16,381 shares in the company, valued at approximately $2,980,195.33. In addition, Director Paul Edward Chamberlain sold 160 shares of the stock on March 10th at an average price of $169.42, for a total transaction value of $27,107.20. Following the completion of the transaction, the director now owns 16,776 shares of the company’s stock, valued at approximately $2,842,189.92.

In the last 90 days, insiders have sold a total of 97,224 shares of VEEV stock worth $16,003,460, and corporate insiders own 13.23% of the company’s stock.

About Veeva Systems, Inc.

Veeva Systems, Inc. is a technology company that provides cloud-based software solutions for the life sciences industry. The company offers a range of products and services, including data management, customer relationship management, and content management solutions. VEEV’s software solutions are designed to help life sciences companies streamline their operations, improve efficiency, and enhance collaboration among teams.

According to Get Rating, VEEV currently has a rating of “Moderate Buy”.

About Veeva Systems and Latest Insider Trades

Veeva Systems, Inc. provides industry cloud solutions for the global life sciences industry. The company’s solutions enable pharmaceutical and other life sciences companies to use modern cloud-based architectures and mobile applications for their most critical business functions, while ensuring regulatory compliance.

To see what other hedge funds are holding VEEV and get the latest 13F filings and insider trades for the company, visit HoldingsChannel.com.

Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Veeva Systems and related companies with MarketBeat.com’s FREE daily email newsletter.

Don’t miss interesting posts on Famousbio

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reduce IT Employee Fatigue: Gartner’s Four-Step Plan

Successful organizations must involve top executives, lower organizational layers, IT, and business…

Arrest made in murder of LA Bishop David O’Connell, sources say

Los Angeles police have arrested a person in reference to the homicide…

Actylis: Leading the Chemical Industry

Actylis, a global manufacturer and sourcing expert of critical raw materials and…

Lumen Technologies: Shareholder Class Action

Investors who purchased or acquired common stock of Lumen Technologies may be…